Developing Microbiome Therapeutics to Improve Efficacy of Drugs and Vaccines

An Empowered Patient Podcastat Medical and Pharma Insider hosted by Karen Jagoda


Stephanie Culler PhD, Co-Founder and CEO of Persephone Biosciences describes how the microbiome, the microbes that exist in our GI tract, impacts our overall health and specifically the immune system.


Their goal is to leverage the impact of a healthy microbiome to improve the effectiveness of drugs and vaccines. By creating the VOICES study, Persephone is looking at a representative population to look at the connection between the microbiome and clearance of viral infections as well as vaccine efficacy to better understand how the microbiome is impacting a patient's response to the COVID-19 vaccines.


Listen to Podcast


Download a Transcript




Website: PersephoneBiosciences.com